Skin autofluorescence as an indicator of advanced glycation end-product accumulation in the prognosis of age-related cardiovascular disease: literature review
- 作者: Lebedev P.1, Davydova N.1, Paranina E.1, Skuratova M.1
-
隶属关系:
- Samara State Medical University
- 期: 卷 14, 编号 1 (2023)
- 页面: 37-48
- 栏目: Reviews
- URL: https://journals.rcsi.science/2221-7185/article/view/134160
- DOI: https://doi.org/10.17816/CS225838
- ID: 134160
如何引用文章
全文:
详细
Advanced glycation end products (AGEs) are represented by heterogeneous molecular structures and their accumulation in organs and tissues reflects the intensity of oxidative stress and glycemia. As a physiological process, aging is associated with AGE accumulation and changing the morphology and functions of the vascular wall. Accelerated AGE accumulation initiates inflammation, contributing to the development of cardiovascular diseases, such as arterial hypertension, coronary heart diseases, and atherosclerosis of peripheral arteries; conditions associated with high cardiovascular risks such as prediabetes, diabetes mellitus type 2, and chronic kidney diseases are also characterized by the accelerated AGEs accumulation. The ability of AGEs to fluorescence underlies noninvasively in blood serum, tissues, and skin using a well-proven technique of autofluorescence, which is little known to domestic specialists. This review presents the possibilities of autofluorescence to reflect arterial wall remodeling, which includes stiffness, vascular endothelial function, atherosclerotic plaque formation, and instability, using modern materials. The review emphasizes the evidence base regarding the ability of this method to predict mortality and cardiovascular events in a large population from low to high risk.
作者简介
Petr Lebedev
Samara State Medical University
Email: palebedev@yahoo.com
ORCID iD: 0000-0003-3501-2354
SPIN 代码: 8085-3904
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, SamaraNaila Davydova
Samara State Medical University
编辑信件的主要联系方式.
Email: palebedev@yahoo.com
ORCID iD: 0000-0003-1956-3690
SPIN 代码: 7892-1422
graduate student
俄罗斯联邦, SamaraElena Paranina
Samara State Medical University
Email: palebedev@yahoo.com
ORCID iD: 0000-0001-7021-4061
SPIN 代码: 9256-8661
MD, Cand. Sci. (Med.), associate professor
俄罗斯联邦, SamaraMaria Skuratova
Samara State Medical University
Email: palebedev@yahoo.com
ORCID iD: 0000-0002-0703-2764
SPIN 代码: 6774-6215
MD, Cand. Sci. (Med.)
俄罗斯联邦, Samara参考
- Salazar J, Navarro C, Ortega Á, et al. Advanced Glycation End Products: New Clinical and Molecular Perspectives. Int J Environ Res Public Health. 2021;18(14):7236. doi: 10.3390/ijerph18147236
- Simm A. Protein glycation during aging and in cardiovascular disease. J Proteomics. 2013;92:248–259. doi: 10.1016/j.jprot.2013.05.012
- Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris). 2010;58(3):214–219. doi: 10.1016/j.patbio.2009.09.014
- Rowan S, Bejarano E, Taylor A. Mechanistic targeting of advanced glycation end-products in age-related diseases. Biochim Biophys Acta Mol Basis Dis. 2018;1864(12):3631–3643. doi: 10.1016/j.bbadis.2018.08.036
- Perrone A, Giovino A, Benny J, Martinelli F. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxid Med Cell Longev. 2020;2020:3818196. doi: 10.1155/2020/3818196
- Reddy VP, Aryal P, Darkwah EK. Advanced Glycation End Products in Health and Disease. Microorganisms. 2022;10(9):1848. doi: 10.3390/microorganisms10091848
- Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 2003;370(Pt 3):1097–1109. doi: 10.1042/BJ20021371
- Hanssen NM, Wouters K, Huijberts MS, et al. Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. Eur Heart J. 2014;35(17):1137–1146. doi: 10.1093/eurheartj/eht402
- Maasen K, van Greevenbroek MMJ, Scheijen JLJM, et al. High dietary glycemic load is associated with higher concentrations of urinary advanced glycation endproducts: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study. Am J Clin Nutr. 2019;110(2):358–366. doi: 10.1093/ajcn/nqz119
- Budoff MJ, Alpert B, Chirinos JA, et al. Clinical Applications Measuring Arterial Stiffness: An Expert Consensus for the Application of Cardio-Ankle Vascular Index. Am J Hypertens. 2022;35(5):441–453. doi: 10.1093/ajh/hpab178
- Laurent S, Boutouyrie P. Arterial Stiffness and Hypertension in the Elderly. Front Cardiovasc Med. 2020;7:544302. doi: 10.3389/fcvm.2020.544302
- Fishman SL, Sonmez H, Basman C, et al. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):59. doi: 10.1186/s10020-018-0060-3
- Zuo L, Prather ER, Stetskiv M, et al. Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments. Int J Mol Sci. 2019;20(18):4472. doi: 10.3390/ijms20184472
- Uribarri J, Stirban A, Sander D, et al. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care. 2007;30(10):2579–2582. doi: 10.2337/dc07-0320
- Xu B, Chibber R, Ruggiero D, et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003;17(10):1289–1291. doi: 10.1096/fj.02-0490fje
- Gryszczyńska B, Budzyń M, Begier-Krasińska B, et al. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension. Int J Mol Sci. 2019;20(16):3942. doi: 10.3390/ijms20163942
- Senatus LM, Schmidt AM. The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases. Front Genet. 2017;8:187. doi: 10.3389/fgene.2017.00187
- Kajikawa M, Nakashima A, Fujimura N, et al. Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function. Diabetes Care. 2015;38(1):119–125. doi: 10.2337/dc14-1435
- Sakaguchi T, Yan SF, Yan SD, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest. 2003;111(7):959–972. doi: 10.1172/JCI17115
- Liu Q, Chen HB, Luo M, Zheng H. Serum soluble RAGE level inversely correlates with left ventricular hypertrophy in essential hypertension patients. Genet Mol Res. 2016;15(2). doi: 10.4238/gmr.15028414
- Raposeiras-Roubin S, Rodiño-Janeiro BK, Grigorian-Shamagian L, et al. Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol. 2012;157(3):397–402. doi: 10.1016/j.ijcard.2011.05.072
- Prasad K, Manish M. Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension? Int J Angiol. 2017;26(1):1–11. doi: 10.1055/s-0037-1598183
- Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004;47(7):1324–1330. doi: 10.1007/s00125-004-1451-2
- Kornilin DV, Grishanov VN, Cherepanov KV. Pulse excitation fluorescence meter for diagnostic purposes. Proc SPIE 10685, Biophotonics: Photonic Solutions for Better Health Care VI. 2018;1068515. doi: 10.1117/12.2306588
- Davydova NA, Lebedev PA, Ayupov AM, et al. Skin autofluorescence parameter as an adverse prognosis factor in patients with peripheral forms of atherosclerosis. Saratov Journal of Medical Scientific Research. 2022;18(4):568–575. (In Russ).
- Zhang Y, Jiang T, Liu C, et al. Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: AHealth Risk Factor Analysis Using the Body Mass Index as a Moderator. Front Endocrinol (Lausanne). 2022;12:766778. doi: 10.3389/fendo.2021.766778
- Saz-Lara A, Álvarez-Bueno C, Martínez-Vizcaíno V, et al. Are Advanced Glycation End Products in Skin Associated with Vascular Dysfunction Markers? A Meta-Analysis. Int J Environ Res Public Health. 2020;17(18):6936. doi: 10.3390/ijerph17186936
- van Eupen MG, Schram MT, van Sloten TT, et al. Skin autofluorescence and pentosidine are associated with aortic stiffening: the Maastricht study. Hypertension. 2016;68(4):956–963. doi: 10.1161/HYPERTENSIONAHA.116.07446
- Birukov A, Cuadrat R, Polemiti E, et al. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study. Cardiovasc Diabetol. 2021;20(1):110. doi: 10.1186/s12933-021-01296-5
- Jujić A, Östling G, Persson M, et al. Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population. Diab Vasc Dis Res. 2019;16(5):466–473. doi: 10.1177/1479164119845319
- Mitchell JD, Paisley R, Moon P, et al. Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: The Walter Reed Cohort Study. JACC Cardiovasc Imaging. 2018;11(12):1799–1806. doi: 10.1016/j.jcmg.2017.09.003
- Pan J, Bao X, Gonçalves I, et al. Skin autofluorescence, a measure of tissue accumulation of advanced glycation end products, is associated with subclinical atherosclerosis in coronary and carotid arteries. Atherosclerosis. 2022;345:26–32. doi: 10.1016/j.atherosclerosis
- Sanchez E, Betriu A, Yeramian A, et al. Skin autofluorescence measurement in subclinical atheromatous disease: results from the ILERVAS project. J Atheroscler Thromb. 2019;26(10):879–889. doi: 10.5551/jat.47498
- Fujino Y, Attizzani GF, Tahara S, et al. Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease. Atherosclerosis. 2018;274:47–53. doi: 10.1016/j.atherosclerosis.2018.03.001
- Hangai M, Takebe N, Honma H, et al., Association of advanced glycation end products with coronary artery calcification in Japanese subjects with type 2 diabetes as assessed by skin autofluorescence. J Atherosclerosis Thromb. 2016;23(10):1178–1187. doi: 10.5551/jat.30155
- Sánchez E, Betriu À, Arroyo D, et al. Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study. PLoS One. 2017;12(1):e0170778. doi: 10.1371/journal.pone.0170778
- Siriopol D, Hogas S, Veisa G, et al. Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis. Int Urol Nephrol. 2015;47(3):563–569. doi: 10.1007/s11255-014-0870-3
- van Waateringe RP, Fokkens BT, Slagter SN, et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia. 2019;62(2):269–280. doi: 10.1007/s00125-018-4769-x
- Jin Q, Lau ESH, Luk AOY, et al. Skin autofluorescence is associated with higher risk ofcardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank. J Diabetes Complications. 2021;35(10):108015. doi: 10.1016/j.jdiacomp.2021.108015
- Boersma HE, van Waateringe RP, van der Klauw MM, et al. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. BMC Endocr Disord. 2021;21(1):14. doi: 10.1186/s12902-020-00676-4
- Shardlow A, McIntyre NJ, Kolhe NV, et al. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospectivecohort study. PLoS Med. 2020;17(7):e1003163. doi: 10.1371/journal.pmed.1003163
- Fraser SD, Roderick PJ, McIntyre NJ, et al. Skin autofluorescence and all-cause mortality in stage 3 CKD. Clin J Am Soc Nephrol. 2014;9(8):1361–1368. doi: 10.2215/CJN.09510913
- Cavero-Redondo I, Soriano-Cano A, Alvarez-Bueno C, et al. Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis. J Am Heart Assoc. 2018;7(18):e009833. doi: 10.1161/JAHA.118. 009833
- deVos LC, Noordzij MJ, Mulder DJ, et al. Skin autofluorescence as a measure of advanced glycation end product deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol. 2013;33(1):131–138. doi: 10.1161/ATVBAHA.112.300016
- de Vos LC, Mulder DJ, Smit AJ, et al. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol. 2014;34(4):933–938. doi: 10.1161/ATVBAHA.113.302731
- Kunimoto M, Yokoyama M, Shimada K, et al. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation. Cardiovasc Diabetol. 2021;20(1):208. doi: 10.1186/s12933-021-01398-0